Internal Medicine · Flushing, NY
NPI
1326001991
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13620 38th Ave Ste 8c
Flushing, NY, 11354
Phone (718) 886-6995
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,109 services
Medicare patients, 2024
60
Average age 73
Drug cost, 2024
$4.0M
24,420 prescriptions
Company payments, 2025
$5,643
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yong M Yu was code 99490 (chronic, principal, and transitional care management), 442 times for 46 patients. In total Yong M Yu billed 1,109 services in 30 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 442 | 46 | $40.38 | $18K |
| 99213 Office E&M - Established | Office | 223 | 57 | $76.19 | $17K |
| 36415 Venipuncture Blood Collection | Office | 78 | 41 | $8.65 | $675 |
| 99212 Office E&M - Established | Office | 70 | 33 | $44.07 | $3,085 |
| 93000 Electrocardiogram | Office | 47 | 39 | $12.94 | $608 |
| 99497 Care Management/Coordination | Office | 46 | 43 | $70.62 | $3,249 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 31 | 31 | $142.39 | $4,414 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 25 | 25 | $27.87 | $697 |
| G0008 Administration of influenza virus vaccine | Office | 25 | 25 | $36.42 | $911 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 23 | 23 | $21.46 | $494 |
| 90661 Vaccine Product | Office | 18 | 18 | $36.11 | $650 |
| 99214 Office E&M - Established | Office | 17 | 13 | $114.08 | $1,939 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 12 | 12 | $184.59 | $2,215 |
By year: 2022 $71K for 1,375 services; 2023 $70K for 1,459 services; 2024 $57K for 1,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 78 | 41 | $8.65 | $675 |
Medicare prescription drug claims, 2024
In 2024, the drug Yong M Yu prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 1,933 prescriptions and refills. In total Yong M Yu wrote 24,420 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 1,933 | 3,449 | 350 | $1.1M |
| Losartan Potassium Generic | 1,781 | 3,776 | 336 | $13K |
| Atorvastatin Calcium Generic | 1,508 | 3,043 | 282 | $11K |
| Amlodipine Besylate Generic | 960 | 2,016 | 187 | $6,048 |
| Raloxifene Hcl Generic | 954 | 2,055 | 198 | $22K |
| Simvastatin Generic | 944 | 1,948 | 177 | $6,112 |
| Metformin Hcl Er Metformin Hcl | 919 | 1,960 | 181 | $9,003 |
| Metoprolol Succinate Generic | 905 | 1,824 | 164 | $10K |
| Tamsulosin Hcl Generic | 754 | 1,507 | 146 | $7,122 |
| Azithromycin Generic | 460 | 460 | 267 | $1,193 |
| Zolpidem Tartrate Generic | 412 | 412 | 132 | $3,199 |
| Famotidine Generic | 364 | 497 | 115 | $3,470 |
| Diclofenac Epolamine Generic | 336 | 379 | 65 | $230K |
| Finasteride Generic | 335 | 636 | 59 | $2,341 |
| Alendronate Sodium Generic | 317 | 551 | 63 | $1,666 |
Brand drugs: 5,640 claims; generic drugs: 18,227 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yong M Yu $5,643 ($5,643 in general payments such as food, travel and fees) from 12 companies. The largest payer was Gilead Sciences, Inc. with $4,661.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 14 | $4,661 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 21 | $313 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $252 |
| GlaxoSmithKline, LLC. GSK | 3 | $65.78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61.59 |
| Esperion Therapeutics, Inc. ESPR | 3 | $54.54 |
| Corcept Therapeutics CORT | 2 | $50 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $46.54 |
| Pfizer Inc. PFE | 2 | $45.96 |
| Abbvie Inc. ABBV | 2 | $36.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.